Abstract 1077: Loss of HER2 via trogocytosis by CD14+ cells in HER2-overexpressing breast cancer cells is associated with diminishing of trastuzumab-mediated antibody-dependent cellular cytotoxicity
2013 ◽
1999 ◽
Vol 53
(3)
◽
pp. 199-207
◽
2016 ◽
Vol 65
(11)
◽
pp. 1325-1335
◽
2014 ◽
Vol 193
(8)
◽
pp. 4261-4272
◽
Keyword(s):